UNSPSC 51351914: Etynodiol diacetate

This classification denotes a therapeutic progestin with the molecular formula C24H32O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62H10A1236, chemically known as 19-norpregn-4-en-20-yne-3,17-diol, diacetate, (3.beta.,17.alpha.)- but more generally known as ethynodiol diacetate, which bears US NIH Compound Identifier 3304. European Medicines Agency schedules Etynodiol diacetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02051MIG.

Most nations, for tariff and trade purposes, schedule etynodiol diacetate under HS 29372300 and SITC 54153. SMILES: CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C.

UNSPSC 51351914 Etynodiol diacetate is a Commodity code for a specific synthetic progestin used in oral contraceptive formulations and hormone replacement therapy products. State and local governments procure this active pharmaceutical ingredient through their health departments, correctional facilities, public health clinics, and institutional pharmacy systems for inclusion in contraceptive and hormonal medications dispensed to patients. The procurement typically occurs as part of larger pharmaceutical supply contracts or through state Medicaid formulary agreements, where the ingredient is purchased in bulk form for compounding or as part of finished-dose preparations.

The source contains no recent state and local contract opportunities tagged to this code.